168 related articles for article (PubMed ID: 31842467)
21. Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice.
Kong Q; Zhang H; Zhao T; Zhang W; Yan M; Dong X; Li P
Int J Mol Med; 2016 Dec; 38(6):1715-1726. PubMed ID: 27840945
[TBL] [Abstract][Full Text] [Related]
22. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
23. Flavonones from
Guo WW; Wang X; Chen XQ; Ba YY; Zhang N; Xu RR; Zhao WW; Wu X
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30154382
[TBL] [Abstract][Full Text] [Related]
24. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease
Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM
World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861
[TBL] [Abstract][Full Text] [Related]
25. Resveratrol alleviates non-alcoholic fatty liver disease through epigenetic modification of the Nrf2 signaling pathway.
Hosseini H; Teimouri M; Shabani M; Koushki M; Babaei Khorzoughi R; Namvarjah F; Izadi P; Meshkani R
Int J Biochem Cell Biol; 2020 Feb; 119():105667. PubMed ID: 31838177
[TBL] [Abstract][Full Text] [Related]
26.
Kim JH; Sim HA; Jung DY; Lim EY; Kim YT; Kim BJ; Jung MH
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31569635
[No Abstract] [Full Text] [Related]
27. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
[TBL] [Abstract][Full Text] [Related]
28. Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation.
Andrade JM; Paraíso AF; de Oliveira MV; Martins AM; Neto JF; Guimarães AL; de Paula AM; Qureshi M; Santos SH
Nutrition; 2014; 30(7-8):915-9. PubMed ID: 24985011
[TBL] [Abstract][Full Text] [Related]
29. Treatment with estrogen protects against ovariectomy-induced hepatic steatosis by increasing AQP7 expression.
Fu X; Xing L; Xu W; Shu J
Mol Med Rep; 2016 Jul; 14(1):425-31. PubMed ID: 27176782
[TBL] [Abstract][Full Text] [Related]
30. Palmitate induces fat accumulation by activating C/EBPβ-mediated G0S2 expression in HepG2 cells.
Zhao NQ; Li XY; Wang L; Feng ZL; Li XF; Wen YF; Han JX
World J Gastroenterol; 2017 Nov; 23(43):7705-7715. PubMed ID: 29209111
[TBL] [Abstract][Full Text] [Related]
31. Lipid accumulation stimulates the cap-independent translation of SREBP-1a mRNA by promoting hnRNP A1 binding to its 5'-UTR in a cellular model of hepatic steatosis.
Siculella L; Tocci R; Rochira A; Testini M; Gnoni A; Damiano F
Biochim Biophys Acta; 2016 May; 1861(5):471-81. PubMed ID: 26869449
[TBL] [Abstract][Full Text] [Related]
32. Impact of activating transcription factor 4 signaling on lipogenesis in HepG2 cells.
Ren LP; Yu X; Song GY; Zhang P; Sun LN; Chen SC; Hu ZJ; Zhang XM
Mol Med Rep; 2016 Aug; 14(2):1649-58. PubMed ID: 27357269
[TBL] [Abstract][Full Text] [Related]
33. Honokiol activates the LKB1-AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes.
Seo MS; Kim JH; Kim HJ; Chang KC; Park SW
Toxicol Appl Pharmacol; 2015 Apr; 284(2):113-24. PubMed ID: 25737164
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of HMGB1 release via salvianolic acid B-mediated SIRT1 up-regulation protects rats against non-alcoholic fatty liver disease.
Zeng W; Shan W; Gao L; Gao D; Hu Y; Wang G; Zhang N; Li Z; Tian X; Xu W; Peng J; Ma X; Yao J
Sci Rep; 2015 Nov; 5():16013. PubMed ID: 26525891
[TBL] [Abstract][Full Text] [Related]
35. Next generation sequencing of RNA reveals novel targets of resveratrol with possible implications for Canavan disease.
Dembic M; Andersen HS; Bastin J; Doktor TK; Corydon TJ; Sass JO; Lopes Costa A; Djouadi F; Andresen BS
Mol Genet Metab; 2019 Jan; 126(1):64-76. PubMed ID: 30446350
[TBL] [Abstract][Full Text] [Related]
36. Actein ameliorates hepatic steatosis and fibrosis in high fat diet-induced NAFLD by regulation of insulin and leptin resistant.
Chen HJ; Liu J
Biomed Pharmacother; 2018 Jan; 97():1386-1396. PubMed ID: 29156528
[TBL] [Abstract][Full Text] [Related]
37. Resveratrol supplement inhibited the NF-κB inflammation pathway through activating AMPKα-SIRT1 pathway in mice with fatty liver.
Tian Y; Ma J; Wang W; Zhang L; Xu J; Wang K; Li D
Mol Cell Biochem; 2016 Nov; 422(1-2):75-84. PubMed ID: 27613163
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of stearoyl-CoA desaturase1 activates AMPK and exhibits beneficial lipid metabolic effects in vitro.
Kim E; Lee JH; Ntambi JM; Hyun CK
Eur J Pharmacol; 2011 Dec; 672(1-3):38-44. PubMed ID: 21970804
[TBL] [Abstract][Full Text] [Related]
39. Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state.
Su H; Li Y; Hu D; Xie L; Ke H; Zheng X; Chen W
Free Radic Biol Med; 2018 Oct; 126():269-286. PubMed ID: 30142454
[TBL] [Abstract][Full Text] [Related]
40. Liver delipidating effect of a combination of resveratrol and quercetin in rats fed an obesogenic diet.
Arias N; Macarulla MT; Aguirre L; Miranda J; Portillo MP
J Physiol Biochem; 2015 Sep; 71(3):569-76. PubMed ID: 25827944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
